Loading
RH
Ryman Healthcare Limited Stock: price and insider trades · New Zealand
No insider purchase over the last 90 days. The latest, by RYM Insider, was filed 04 Jun 2026.
Ryman Healthcare Limited: what insiders have been doing
Ryman Healthcare Limited is a Health Care company. Its directors and officers file their transactions with NZX. The last twelve months, up to 24 October 2026, brought 10 filings signed by 2 insiders.
Only purchases show up on the open market, 7 purchases in all worth €446k, filed by 1 insider. Unlike grants, an open-market purchase is paid for by the insider, at the market price. At €124k, the purchase published on 9 December 2025 by RYM Insider is the largest of the period.
The last insider purchase was made public on 4 June 2026, 141 days ago. Publication is fast: at least half of the trades appear on NZX on the same day. The shorter that gap, the sooner other investors can see what insiders have done.
Compared with its exchange (113 companies, median 8 filings), a count of 10 filings is above the norm. Since 2017, the database holds 32 purchases and 4 sales by insiders of the company.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. Every figure here comes from the filings published by NZX and describes the past, not future prices; it is not investment advice.
Insider Decl.
131
Thresholds
n/a
Buy Volume
€2M
32 ops. · all time
Sell Volume
€521,750
4 ops. · all time
Who traded when
BuySaleRYM Insider14 buys1 sale
Since the insiders bought
- -19.1%Entry NZ$2.28 · Close 19 Oct 2026 NZ$1.85
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Ryman Healthcare Limited Strong Buy (bullish), based on 4 analysts. Average price target: NZ$2.92.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 15,830 of 26,280 companies
45.2
score / 100
Value49
Quality41
FCF yld16%
Earn yld-23%
EV/EBITDA·
ROE-4.1%
Gross mgn100%
Net mgn-61%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended March 2025 · cache
NZ$1.86
Analyst consensus
4 analystsStrong buy
NZ$2.56Target NZ$2.92(+57%)NZ$3.50
Income statement
RevenueNZ$713.8M
Gross profitNZ$713.8M100% margin
EBITDA-NZ$27.2M-4% margin
Net income-NZ$436.8M-20.1% margin
Valuation
PER (forward)10.6x
P/Book0.5x
Beta0.37
Balance sheet & cash
Market capNZ$1.9B
Total debtNZ$1.7B
Free Cash FlowNZ$303.2M
Debt / Equity39%
Profitability & ownership
ROE-4.1%
ROA0.2%
% insiders12.1%
% institutions20.8%
Last declaration on 1 July 2026
Declarations131 total
●
Executives
0NZX
26,238 shares@ NZ$2.2752.6% of flowOrdinary ShareNZX Main BoardNZX:473911
Canonical exit: 2 Sept 2026 (T+90)
8,800 shares@ NZ$2.260.9% of flowOrdinary ShareNZX Main BoardNZX:473826
Canonical exit: 31 Aug 2026 (T+90)
96,926 shares@ NZ$2.26249.6% of flowOrdinary ShareNZX Main BoardNZX:473825
Canonical exit: 31 Aug 2026 (T+90)
51,000 shares@ NZ$2.26775.0% of flowOrdinary ShareNZX Main BoardNZX:473824
Canonical exit: 1 Sept 2026 (T+90)
86,514 shares@ NZ$2.30028.7% of flowOrdinary ShareNZX Main BoardNZX:473647
Canonical exit: 26 Aug 2026 (T+90)
●
Executives
0NZX
Ordinary ShareNZX Main BoardNZX:468130
7,253 shares@ NZ$2.940.4% of flowOrdinary ShareNZX Main BoardNZX:464635
Canonical exit: 15 Mar 2026 (T+90)
86,977 shares@ NZ$2.87434.9% of flowOrdinary ShareNZX Main BoardNZX:464222
Canonical exit: 9 Mar 2026 (T+90)
Ordinary ShareNZX Main BoardNZX:456493
19,580 shares@ NZ$2.501.0% of flowOrdinary ShareNZX Main BoardNZX:456171
Canonical exit: 2 Nov 2025 (T+90)
70,000 shares@ NZ$2.58383.7% of flowOrdinary ShareNZX Main BoardNZX:455338
Canonical exit: 16 Oct 2025 (T+90)
●
Executives
0NZX
25,000 shares@ NZ$2.25151.1% of flowOrdinary ShareNZX Main BoardNZX:454433
Canonical exit: 29 Sept 2025 (T+90)
20,000 shares@ NZ$2.20830.9% of flowOrdinary ShareNZX Main BoardNZX:454176
Canonical exit: 24 Sept 2025 (T+90)
8,391 shares@ NZ$2.20310.4% of flowOrdinary ShareNZX Main BoardNZX:454141
Canonical exit: 23 Sept 2025 (T+90)
Ordinary ShareNZX Main BoardNZX:450642
Ordinary ShareNZX Main BoardNZX:450553
Ordinary ShareNZX Main BoardNZX:450432
●
Executives
0NZX
Ordinary ShareNZX Main BoardNZX:448541
Ordinary ShareNZX Main BoardNZX:447859
●
Executives
0NZX
●
Executives
0NZX
25 of 131 declarations
About Ryman Healthcare Limited
RYM is a company listed on the XNZE market. It operates in the financial sector, providing various investment and asset management services.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
